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al., 2010). These countries are undergoing 
epidemiological transition from 
communicable to non-communicable 
diseases. Epidemiological transition has been 
closely linked to changes in the 
demographic, social and economic status of 
various populations, causing a global rise in 
chronic diseases, especially CVD (Oladapo et 
ABSTRACT 
Increase in plasma free fatty acids (FFAs) concentrations may cause cellular damage via the induction 
of oxidative stress. The aim of this present study was to investigate FFAs and oxidative stress in hy-
pertension co-morbidly occurring with Type 2 Diabetes Mellitus (T2DM). Age and sex matched control 
subjects (n=150) and patients (n=470) [hypertensive nondiabetics (HND, n=179), normotensive diabet-
ics (ND, n=132), hypertensive diabetics (HD, n=159)] presenting at the Medical Out-Patient Clinic of 
the State Hospital, Abeokuta, Nigeria were recruited. Fasting plasma glucose, creatinine, urea, FFAs, 
thiobarbituric acid reactive substances (TBARS) were determined spectrophotometrically. The pres-
ence of either or both diseases resulted in significant increase (p<0.05) in the plasma FFAs and 
oxidative stress marker-TBARS in different compartments (plasma, erythrocytes andlipoproteins) for 
both male and female patients when compared with their control counterparts. The increase in FFAs 
was more marked in comorbidity female when compared with other female patients. There was 
significant (p<0.05) difference in gender FFAs concentrations. In both controls and patients, FFAs in 
plasma are significantly (p<0.05) higher in male when compared with their female counterparts. This 
research revealed biochemical variations in hypertension co-morbidly occurring with 
T2DMcharacterised by gender-related elevation in FFAs and enhanced oxidative stress. Plasma FFAs 
might be a good biomarker predicting the occurrence and development of hypertension and/or T2DM. 
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INTRODUCTION 
All over the world, cardiovascular diseases 
(CVD) and the metabolic syndrome are ma-
jor causes of morbidity and mortality, 
including sudden death. CVD is emerging 
as a significant health problem in sub-
Saharan countries such as Nigeria, with a 
population of over 180 million (Oladapo et 
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al., 2010). The World Health Organization 
estimates that the number of people with 
type 2 diabetes mellitus (T2DM) will 
increase to 366 million by the year 2030 
(Arnetz et al., 2014). The steep rise of 
communicable diseases such as 
hypertension and T2DM and associated 
complications go along with increasing 
evidence of clinically (epidemiology, 
pathophysiology, treatment, and outcomes) 
important sex differences. While T2DM in 
men is more frequently diagnosed at lower 
age and body mass index; the most 
prominent risk factor, which is obesity, is 
more common in women (Kautzky-Willer et 
al., 2016). Hypertension, type 2 DM, 
oxidative stress, endothelial dysfunction and 
inflammation play significant roles in the 
pathogenesis of cardiovascular diseases. 
Plasma free fatty acids (FFAs) as the main 
source of energy in the liver, heart, kidney, 
muscle, lung, testis, brain and the adipose 
tissue; can enhance the reaction of oxidative 
stress, cause endothelial dysfunction 
(Chinen et al., 2007), induced atherosclerosis 
(He et al, 2014) and links with increased 
insulin resistance (Gruzdeva et al., 2013). It 
has been shown that increased plasma FFAs 
can predict development of CAD in healthy 
men. Also increased free fatty acid level is 
known to have a causal relationship with 
oxidative stress and endothelial dysfunction 
(Yamato et al., 2007; Du et al., 2006; Furuka-
wa et al., 2004; Yamaguchi et al., 2006). In 
hypertension pathogenesis, angiotensin I is 
converted to angiotensin II by angiotensin 
converted enzyme (ACE), angiotensin II 
activates the NADPH oxidase which in turn 
catalyzes the oxidation of NADPH to 
NADP+, in the process of O2 accepting 
electrons from NADPH, ROS are generat-
ed which inhibit endogenous nitric oxidixe 
synthase (eNOS). eNOS catalyses the syn-
thesis of NO, the endogenous derived re-
laxing factor from L-arginine. It has been 
shown that elevated FFAs behave like angio-
tensin II by activating NADPH oxidase over 
expression, which caused increased ROS 
generation, which in turn decreased the syn-
thesis of NO and so resulted in the endothe-
lial dysfunction (Chinen et al, 2007, Zhou et 
al., 2009). It has also been reported that insu-
lin resistance is an independent predictor of 
cardiovascular disease (An et al., 2012) and 
the increased plasma FFAs levels were a sig-
nificant cause of obesity-associated insulin 
resistance (Boden, 2011). Furthermore, ele-
vated FFAs promotes uptake of oxidized 
LDL in macrophages, an essential step in 
development of atherosclerosis (Ishiyama et 
al., 2010). This study aims to investigate the 
plasma FFAs and oxidative stress marker in 
hypertension, type 2 diabetes mellitus, and 
their co-morbidity, and also to determine if 
FFAs varies with gender. 
 
MATERIALS AND METHODS 
Study area and subjects 
The study was carried out in Abeokuta the 
capital city of Ogun State, Nigeria. They ba-
sically consume typical Nigerian low fat, high 
carbohydrate and protein diets. Apart from 
this, they live an active life-style in the com-
munity (Akamo et al., 2015). Patients pre-
senting at the Medical Out-patient Clinic, 
State Hospital, Ijaiye, Abeokuta, Ogun State, 
Nigeria were used for the study. The proto-
col for the study was approved by the Re-
search and Ethics Committee of the State 
Hospital as well as the Postgraduate Com-
mittee of the Department of Biochemistry, 
Federal University of Agriculture, Abeokuta. 
Patients (diagnosed by a Consultant Physi-
cian in the Department of Internal Medicine 
of the State Hospital) were made of age and 
sex-matched indigenous Nigerian normogly-
caemic hypertensives; normotensive type 2 
diabetes mellitus and patients with co-
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morbidity of hypertension and type 2 diabe-
tes. The diagnosis of diabetes mellitus was 
based on the WHO criteria (Akamo et al., 
2015). Patients on oral hypoglycaemic drugs 
or whose diagnosis of diabetes was made at 
the age of 40 years and above with no rec-
ord of ketosis were considered to have type 
2 diabetes mellitus. Hypertensive patients 
were diagnosed based on World Health Or-
ganisation-International Society of Hyper-
tension Guideline cut-off point of 140 
mmHg and above for systolic blood pres-
sure (SBP) and/or 95 mmHg and above for 
diastolic blood pressure (SBP), and also if it 
was previously detected and the subject was 
on treatment (Idogun et al., 2007). Pulse 
pressure (PP) was calculated as SBP minus 
DBP. Mean arterial pressure (MAP) was 
estimated as (SBP+2DBP)/3 (Akamo et al., 
2015). Inclusion criteria included being hy-
pertensive for ≥ one year, use of neutral 
antihypertensive agents such as calcium 
channel blockers, angiotensin converting 
enzyme inhibitors, and angiotensin II recep-
tor blockers. Excluded from the study dur-
ing routine interviews, clinical investigations 
and laboratory tests were patients with a his-
tory of smoking, drinking alcohol, human 
immunodeficiency virus (HIV), systemic lu-
pus erythematosus, systemic inflammation or 
systemic infection, taking oral contracep-
tives, lipid lowering drugs. Age and sex-
matched volunteers certified clinically and 
biochemically to be healthy, on no medica-
tion; normotensive and normoglycaemic 
served as controls. They were made of staff 
and students of Federal University of Agri-
culture, Abeokuta, Nigeria. They were re-
cruited in the study at the same period with 
the patients. Participation in the study by 
individual subject was voluntary. Before en-
rollment in the study, all subjects were in-
formed about the objectives and require-
ments of the study, as well as the risks and 
discomfort that might be involved in partici-
pating in the study. Demographic data in-
cluding age, sex, race, and duration of hyper-
tension and diabetes were collected using 
questionnaire (Akamo et al., 2015). Table 1 
summarizes the study population. 
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Table 1. Study population 
Subject Male Female 
Control 74 76 
Hypertensive non-diabetics 76 103 
Normotensive diabetics 64 68 
Hypertensive diabetics 68 91 
Collection of blood samples  
Blood samples (10.0 ml) were collected be-
tween 08.00 a.m. and 11.00 a.m. on each 
clinic day from the antecubital vein of the 
participants after an overnight fast for 12-14 
hours. The blood was transferred into a 
lithium heparin anti-coagulated tube, and 
mixed gently by inverting the stoppered tube 
several times. The blood samples were 
stored in a cooler box and transferred to the 
laboratory for analyses. Plasma was separated 
from erythrocytes. Both plasma and erythro-
cytes were stored at -200C for further anal-
yses. 
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Determination of free fatty aids 
Plasma free fatty acids (FFAs) were deter-
mined according to the method of Soloni 
and Sardina (1973) as modified by Brunk 
and Swanson (1981). Briefly, to 100 μl of 
plasma was added 300 μl of copper reagent 
and 2 ml of chloroform. This was shaken 
with a vertical shaker for 10 min and centri-
fuged. After centrifugation, the chloroform 
layer was removed and to this were added 1 
ml of cuprizone and 100 μl of ammonia 
reagent. The contents were shaken briefly 
by hand and absorbance read at 620nm 10 
min after adding ammonia reagent. A stand-
ard curve of palmitic acid taken through the 
same procedure was used to calculate the 
concentrations of FFA in the plasma sam-
ples. 
 
Determination of lipid peroxidation 
Plasma, erythrocytes and lipoproteins lipid 
peroxidation was estimated colorimetrically 
by thiobarbituric acid reactive substances 
(TBARS) method of Buege and Aust 
(1978). Plasma/erythrocytes/HDL/
LDL+VLDL (0.1 ml) was treated with 2.0 
ml of TBA‑TCA‑HCI (1: 1: 1, v/v/v) 
reagent (thiobarbituric acid 0.37%, 0.25 N 
HCI and 15% TCA) and incubated in a 
water bath at 95 oC for 15 minutes. The 
tube was then placed on ice, centrifuged 
and the absorbance of clear supernatant was 
measured against blank at 535 nm. TBARS 
(malondialdehyde, MDA) content was 
estimated using the equation: 
MDA concentration (µM) = A / (1.55 X 
106 x b). Where A is the absorbance and b 
is the path length. 
 
Statistical analysis 
Data obtained were entered into SPSS 
(Statistical Package for Social Sciences) soft-
ware for Window version 16 (SPSS Inc., 
Chicago, Illinois, USA). Data were ex-
pressed as Mean±S.E.M. Analysis of Vari-
ance (ANOVA) was carried out to test for 
the level of homogeneity among the groups. 
Where heterogeneity occurred, the groups 
were separated using Duncan Multiple Range 
Test (DMRT), p values of < 0.05 were con-
sidered to be statistically significant.  
 
RESULTS 
The demographic and clinical characteristics 
of patients and controls are shown in Table 
2. The controls, hypertensive non-diabetics 
(HND), normotensive diabetic (ND) and 
hypertensive diabetics (HD) were similar (p 
> 0.05) in age. The duration of diagnosis of 
hypertension was 5.04±2.19 years among the 
HND male and 4.87±1.60 years among the 
HD male; it was 5.26±1.66 years vs 
4.94±1.62 years among the HND female and 
HD female respectively (p < 0.05). The du-
ration of diagnosis of diabetics was also simi-
lar (p > 0.05) between the ND male, HD 
male, ND female and HD female; 4.07±1.55 
years, 4.05±1.48 years, 4.22±1.19 years and 
3.98±1.09 years respectively. In the diabetic 
patients fasting plasma glucose (FPG) was 
similar (p > 0.05) among the ND male and 
ND female (196.42±3.66 mg/dLvs 
188.97±4.43 mg/dL (p > 0.05) but signifi-
cantly (p < 0.05) higher when compared with 
HD male and HD female patients 
(174.39±3.73 mg/dLvs 172.24±3.71 mg/
dL). Blood pressure increased significantly (p 
< 0.05) among the HND male, HD male, 
HND fema le  and HD fem a le 
(171.26±3.79/109.25±2.12 mmHg, 
177 .69±3 .16/111 .13±2 .17  mm Hg, 
168.98±2.80/105.17±1.80 mmHg and 
173.54±3.08/106.01±1.97) respectively 
when compared with their corresponding 
controls. In both sexes, the pulse pressure 
(PP), mean arterial pressure (MAP) and heart 
rate were significantly (p < 0.05) increased in 
HND and HD when compared with their 
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respective control counterparts. While no 
significant difference (p > 0.05) was ob-
served in the mean packed cell volume 
(PCV) and haemoglobin (Hb) values of ND 
male, ND female and HD female when 
compared with their control counterparts; 
PCV and Hb values of HND male and 
HND female increased significantly (p > 
0.05). However, the PCV and Hb of HD 
male decrease significantly (p < 0.05). Plas-
ma creatinine increased significantly (p < 
0.05) as a result of the presence of either or 
both diseases. The increase was more 
marked in HD male. While ND male plas-
ma urea has no significant (p > 0.05) differ-
ence when compared with their control 
counterparts, plasma urea in other patients 
increased significantly (p < 0.05), the in-
crease was more marked in HND male. 
Quantitatively plasma urea of the male and 
female patients was between 8% to 18% 
and 20% to 33% respectively higher than 
their control counterparts. There was signif-
icant (p < 0.05) difference in gender creati-
nine and urea concentration. In both con-
trols and patients, plasma creatinine and 
urea were significantly (p < 0.05) higher in 
male when compared with their female 
counterparts. 
 
Figure 1 illustrates theeffects of 
hypertension and/or type 2 diabetes 
mellitus on plasma FFAs. Thepresence of 
either or both diseases resulted in 
significant alterations in the plasma FFAs of 
the subjects (p < 0.05). In the plasma of the 
patients, there were statistically significant 
(p < 0.05) increase in the mean values of 
FFAs for both male and female patients 
when compared with their control 
counterparts. The increase was more marked 
in comorbidity female when compared with 
other patients. Quantitatively plasma FFAs 
contents of the male and female patients 
were between 62.42 % to 78.62 % and 19.57 
% to 60.74 %higher than their respective 
control counterparts. There was significant 
(p < 0.05) difference in gender FFAs 
concentration. In both controls and patients, 
FFAs in plasma are significantly (p < 0.05) 
higher in male when compared with their 
female counterparts. 
 
Table 3 shows the oxidative stress as 
measured by the levels of thiobarbituric acid 
reactive substances (TBARS) in different 
compartment (plasma, erythrocytes 
andlipoproteins) of the subjects. The 
presence of hypertension, T2DM or 
comobidity resulted in significant (p < 0.05) 
increase in TBARS levels in the entire 
different compartment except in the plasma 
and HDL of hypertensive non-diabetics 
where a similar (p > 0.05) TBARS levels was 
observed when compared with the CF. 
Quantitatively, plasma TBARS levels of the 
male and female patients was between 71% 
to 91% and 14% to 70% higher respectively 
than their control counterparts, while that of 
erythrocytes TBARS was between 77% to 
95% and 40% to higher 175% respectively 
than their control counterparts, whereas 
HDL TBARS of the male and female 
patients was between 1.88 to 2.54 times and 
1.36 to 3 times higher than their respective 
control counterparts. Also LDL+VLDL 
TBARS of the male and female patients was 
between 2.47 to 2.94 times and 2.14 to 2.76 
times higher than their respective control 
counterparts. 
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DISCUSSION 
Due to the large and growing literature re-
garding hypertension, diabetes and hyperlip-
idaemia as a risk factor for cardiovascular 
disease in African populations, and the in-
creasing incidents of death due to cardio-
vascular disease in both urbanized and un-
der-developed rural countries in Africa 
(Glew et al., 2002, Oladapo et al., 2010), it is 
imperative to determine possible risk fac-
tors accounting for this scenario. One of 
such risk factors is abnormal lipid profile; 
hence we were compelled to characterize 
the plasma free fatty acids (FFAs) and we 
also compare our data with that for popula-
tion outside Africa. 
 
The major finding of this study was that the 
presence of hypertension and/or T2DM 
perturbs the metabolism of FFAs in the 
plasma of the patients. These perturbations 
were reflected as up-regulation of the 
concentrations of the free fatty acids and 
oxidative stress. 
 
The significant elevated FFAs implies in-
creased mobilization of triacylglycerols 
from the adipose tissue; decrease hepatic 
uptake of FFAs hence decrease energy me-
tabolism (production); enhanced oxidative 
stress, endothelial dysfunction, increased 
inflammation; and increased uptake of oxi-
dized LDL in macrophages which is an es-
sential step in development of atherosclero-
sis. 
 
To maintain normal homeostasis, the or-
ganism must maintain physiological levels 
of metabolites in its diverse metabolic pro-
cess. A distortion of these levels might have 
serious physiological consequences for the 
organism. In this study, an increase was ob-
served in patients’ plasma FFAs. FFAs in 
plasma are derived from hydrolysis of adi-
pose tissue’s triacylglycerols. Hence, eleva-
tion of plasma free fatty acids also implies 
increased mobilization of these lipids from 
the adipose tissue (Newsholme and Start, 
1981). Mobilization of fatty acids is known 
to occur in higher animals in response to 
both psychological and physiological stress 
(Newsholme and Start, 1981, Ademuyiwa et 
al., 2008). 
 
Increased free fatty acid level is known to 
have a causal relationship with oxidative 
stress (Yamato et al., 2007; Du et al., 2006; 
Furukawa et al., 2004; Yamaguchi et al., 
2006). Oxidative stress as measured by thio-
barbituric acid reactive substances increased 
significantly in different compartments 
(plasma, erythrocytes and lipoprotiens) of 
the patients. Thus, the observation of elevat-
ed plasma FFAs in the patients suggest a hy-
pertension and T2DM-indused augmenta-
tion of triacylglycerols hydrolysis resulting 
into FFAs by the triacylglycerols lipase and 
the attendant increased mobilization of the 
FFAs into the plasma. The physiological 
consequences of this elevated plasma FFAs 
could be diverse and could be viewed from 
the metabolic role of FFAs. Free fatty acid is 
the major source of metabolic fuel in many 
tissues including the liver, heart, kidney, 
muscle, lung, testis, brain and the adipose 
tissue, although the brain cannot extract 
them from the blood (Kurokawa et al., 1985). 
Thus, the increased plasma FFAs in the 
hypertension and T2DM patients indicate 
that hepatic uptake of these lipids was 
inhibited by these diseases, hence 
compromising energy metabolism 
(production) in the liver (Ademuyiwa et al., 
2008). 
 
There is growing evidence that FFAs con-
tribute to sudden cardiac death, also an ex-
cess of FFAs has been implicated in insulin 
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resistance and hepatic steatosis (Oliver, 
2006; Blaak, 2003). Furthermore, elevated 
FFAs are associated with atherosclerosis 
and hypertension. Fatty acid oxidation sup-
plies the heart with ~70% of its energy but 
an overwhelming delivery of plasma FFAs 
to the heart, as it is observed in acute coro-
nary syndrome and heart failure, may con-
tribute to myocardial dysfunction (Pilz et al., 
2007). High FFAs and subsequent increased 
utilization of fatty acids for energy genera-
tion in the ischaemic myocardium may 
cause a ‘metabolic crisis’ in patients with 
CAD because fatty acid oxidation requires 
more oxygen when compared with the use 
of glucose (Pilz et al., 2007). Also elevated 
FFAs may be directly involved in the devel-
opment of atherosclerosis because it was 
reported that FFAs are associated with en-
dothelial dysfunction and induce endothelial 
apoptosis and the expression of endothelial 
adhesion molecules (Oram and Bornfeldt, 
2004). Further, pro-atherosclerotic features 
of FFA involve their contribution to 
macrophage to foam cell formation and 
their pro-inflammatory effects (Oram and 
Bornfeldt, 2004). Apart from this, high 
concentrations of FFAs have been shown 
to exert pro-arrhythmic actions (Oliver, 
2006). The population-based Paris 
Prospective study has already shown that 
elevated levels of FFA are predictive for 
sudden cardiac death (Pilz et al., 2007) 
which is one of the outcomes of 
hypertension. 
 
Oxidative stress as measured by TBARS 
increased in plasma, erythrocytes and lipo-
proteins. The greatest increase was ob-
served in concurrent hypertensive T2DM 
patients in all the compartments (plasma, 
erythrocytes and lipoproteins). It is well 
demonstrated that increased oxidative stress 
underlies the pathophysiology of hyperten-
sion by directly influencing vascular cell walls 
and oxidative stress has been associated with 
the onset of cardiovascular complications in 
subjects with the metabolic syndrome (Shin 
et al., 2009). Several observational and 
experimental studies showed impaired 
antioxidant systems with decrease in 
antioxidant capacity and increase in lipid 
peroxidation in MetS (Shin et al., 2009), 
which is consistent with our results. 
Hyperglycemia, a key component of the 
MetS, might trigger oxidative stress by 
several mechanisms either independently or 
associated with other conditions. It includes 
glucose auto-oxidation, advanced glycated 
end product (AGE) formation, abnormal 
arachidonic acid metabolism and its coupling 
to cyclooxygenase catalysis (Grattagliano et 
al., 2008). The enhanced lipid peroxidation in 
hypertension with diabetes, shown in the 
present study, can be explained, in part, 
through the mechanisms mentioned above. 
Considering the atherogenic effect of 
oxidative alterations in the atherosclerotic 
process, our results provide a possible 
mechanism which links MetS in 
hypertension to increased cardiovascular 
risks. 
 
Since the male and female controls in the 
present study were of approximately the 
same age as the patients who had experi-
enced hypertension and/or T2DM, we did 
not have to be concerned that our conclu-
sions regarding lipid profiles levels in the 
patient and control groups may have been 
confounded by age considerations. Further-
more, the possible confounding variable of 
age appears not to have been a factor in our 
study because when we tested for possible 
correlations between LDL-cholesterol, total 
cholesterol, HDL-cholesterol or triacylglyc-
erols versus age (table not shown) in both 
female and male pairs, none was found. 
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However, sex was found to be a possible 
determinant of the pattern of lipid profile 
levels in the patients. 
 
There was significant difference in gender 
FFAs concentration. In both controls and 
patients, FFAs in plasma are significantly (p 
< 0.05) higher in male when compared with 
their female counterparts. In this report, we 
noted that elevated plasma FFAs were 
found to be significantly higher in males 
than in females. Cook et al. (2000) in their 
report on gender differences in pattern of 
dyslipidaemia noted that elevated LDL-C 
and reduced HDL-C were more commonly 
documented in females than males. Bowden 
(2010) found gender differences in the 
HDL-C, LDL-C and TAG components of 
the lipid profile in non-diabetic individuals. 
From the foregoing it is evident that gender 
differences are consistently noted in other 
lipids apart from FFAs (which was shown 
in our study) in apparent healthy individuals 
and patient with hypertension and/or 
T2DM. 
 
CONCLUSION 
This research revealed biochemical varia-
tions in hypertension and/or T2DM char-
acterised by gender-related elevation in 
FFAs and oxidative stress. Up-regulation of 
plasma FFAs and oxidative stress marker 
(malondialdehyde in plasma, erythrocytes 
and lipoproteins) in hypertension and/or 
T2DM were more pronounced in male than 
their female counterparts.  
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